-+ 0.00%
-+ 0.00%
-+ 0.00%
ROVI swings to H1 net profit of EUR 84.38 million; net sales rise 9.4% to EUR 344.16 million
Share
Listen to the news
ROVI swings to H1 net profit of EUR 84.38 million; net sales rise 9.4% to EUR 344.16 million
  • Laboratorios Farmacéuticos ROVI posted H1 net profit attributable to shareholders of EUR 84.48 million, turning from a loss a year earlier.
  • Net sales rose to EUR 344.16 million, while operating income climbed to EUR 103.13 million.
  • Basic EPS increased to EUR 1.65.
  • Cash and cash equivalents rose to EUR 126.97 million at June 30, while total assets increased to EUR 1.13 billion.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Laboratorios Farmacéuticos ROVI SA published the original content used to generate this news brief on July 23, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending